Cross-ancestry genetic investigation of schizophrenia, cannabis use disorder, and tobacco smoking

• Published in: Neuropsychopharmacology (New York, N.Y.) N.Y.), 2024-06, Vol.49 (11), p.1655-1665
• Main Authors: Johnson, Emma C, Austin-Zimmerman, Isabelle, Thorpe, Hayley H A, Levey, Daniel F, Baranger, David A A, Colbert, Sarah M C, Demontis, Ditte, Khokhar, Jibran Y, Davis, Lea K, Edenberg, Howard J, Di Forti, Marta, Sanchez-Roige, Sandra, Gelernter, Joel, Agrawal, Arpana
• Format: Article
• Language: English
• ISSN: 0893-133X; 1740-634X; 1740-634X
• DOI: 10.1038/s41386-024-01886-3

Individuals with schizophrenia frequently experience co-occurring substance use, including tobacco smoking and heavy cannabis use, and substance use disorders. There is interest in understanding the extent to which these relationships are causal, and to what extent shared genetic factors play a role. We explored the relationships between schizophrenia (Scz; European ancestry N = 161,405; African ancestry N = 15,846), cannabis use disorder (CanUD; European ancestry N = 886,025; African ancestry N = 120,208), and ever-regular tobacco smoking (Smk; European ancestry N = 805,431; African ancestry N = 24,278) using the largest available genome-wide studies of these phenotypes in individuals of African and European ancestries. All three phenotypes were positively genetically correlated (r s = 0.17-0.62). Genetic instrumental variable analyses suggested the presence of shared heritable factors, but evidence for bidirectional causal relationships was also found between all three phenotypes even after correcting for these shared genetic factors. We identified 327 pleiotropic loci with 439 lead SNPs in the European ancestry data, 150 of which were novel (i.e., not genome-wide significant in the original studies). Of these pleiotropic loci, 202 had lead variants which showed convergent effects (i.e., same direction of effect) on Scz, CanUD, and Smk. Genetic variants convergent across all three phenotypes showed strong genetic correlations with risk-taking, executive function, and several mental health conditions. Our results suggest that both shared genetic factors and causal mechanisms may play a role in the relationship between CanUD, Smk, and Scz, but longitudinal, prospective studies are needed to confirm a causal relationship.